Log In
Print
BCIQ
Print
Print this Print this
 

IV solithromycin (CEM-101) (formerly OPT-1068)

  Manage Alerts
Collapse Summary General Information
Company Optimer Pharmaceuticals Inc.
DescriptionIV formulation of a fluoroketolide/macrolide antibiotic
Molecular Target Ribosomal 50S subunit
Mechanism of ActionRibosomal 50S subunit inhibitor
Latest Stage of DevelopmentPhase I
IndicationPneumonia
Partner

Cempra Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today